Democratizing the Clinical Trials Agenda in Dermatology.

The author discusses the significance of democratizing randomized clinical trials (RCTs) in the field of dermatology in Great Britain. He explains that RCTs are essential in assessing the efficacy of skin disease treatment but its usefulness is limited in the quality of design and reporting and the clinical question that the trials address. He cites that the challenges can be addressed by forming a network of like-minded people such as the UK Dermatology Clinical Trials Network (UK DCTN).